Skip to the line map
Before the Needle

Are Mesenchymal Stem Cells and Mesenchymal Stromal Cells the Same Thing?

  • Updated November 14, 2026
  • Stop 2 of 6 on the Stem cell basics line

Not exactly. Both names usually describe the same kind of laboratory cell population, which is why both are abbreviated “MSC.” But they make different claims. “Stem cell” claims the cells can renew themselves and turn into several tissue types in the body. “Stromal cell” makes no such claim. The International Society for Cell & Gene Therapy recommends “mesenchymal stromal cells” for ordinary mixed populations and reserves “stem cells” for cells with rigorous evidence of stemness.

What does MSC stand for in scientific papers?

MSC can stand for mesenchymal stem cells, mesenchymal stromal cells, or multipotent stromal cells. Some researchers have also proposed a different name, “medicinal signaling cells,” to emphasize what the cells are thought to do in the body rather than claim stem cell behavior; that proposed name has not replaced the others. The cells involved are typically fibroblast-like cells that stick to plastic in a culture dish and can be grown from bone marrow, fat, umbilical cord tissue and other sources.

The ambiguity has a history. “Mesenchymal stem cell” was introduced in the early 1990s. In 2005, the society now called the International Society for Cell & Gene Therapy (ISCT) published a position stating that this population should be called multipotent mesenchymal stromal cells, with “mesenchymal stem cells” used only for cells meeting specified stem cell criteria. The two usages kept spreading side by side anyway. ISCT’s 2019 position statement notes that a literature search returned roughly as many results for one term as for the other.

So when you see “MSC” in a paper or advertisement, you cannot tell from the acronym alone which claim is being made.

What properties make a cell a true stem cell?

A stem cell has two defining abilities, as the National Institutes of Health explains in its stem cell basics:

  • Self-renewal: when it divides, it can produce more stem cells, so the population maintains itself.
  • Differentiation: it can give rise to more specialized cell types.

For a mesenchymal stem cell, the claim would be that a single cell can renew itself and produce several tissue types, such as bone, cartilage and fat, and do so in a living body.

Laboratory characterization often relies on other evidence: whether cells stick to plastic, which proteins appear on their surface (markers), and whether a bulk population can be pushed toward bone, cartilage or fat in a dish. Those tests are useful for identifying and standardizing a cell preparation. They do not, on their own, prove self-renewal and multilineage potential in the body. ISCT’s 2019 statement points out that no surface markers currently distinguish bulk stromal populations from rarer true stem cells within them.

Why do scientists prefer “mesenchymal stromal cells” in many contexts?

The 2019 ISCT position statement on nomenclature, published in Cytotherapy, makes three recommendations:

  1. Name the tissue of origin. Bone marrow-derived, adipose-derived and umbilical cord-derived cells behave differently, so labels such as BM-MSC or AD-MSC are preferred.
  2. Use “stromal cells” for bulk, unfractionated populations. That label fits mixed preparations rather than purified populations of proven stem cells.
  3. Use “stem cells” only with rigorous evidence, including functional evidence of self-renewal and differentiation, and avoid calling cells stem cells in the absence of in vivo data.

ISCT also recommends functional assays that test the mechanism a product is supposed to work by, such as what the cells secrete or how they affect immune responses. A name that does not presume stemness leaves room for those mechanisms.

Does a stem cell label prove a treatment grows new tissue?

No. A name describes what the cells are claimed to be. Whether an injection of those cells regenerates tissue in a particular disease is a separate clinical question, answered only by controlled human trials that measure tissue structure.

That distinction is visible in regulation. The only FDA-approved mesenchymal cell product as of November 14, 2026, Ryoncil, is described by FDA as a mesenchymal stromal cell therapy, and its approval is for steroid-refractory acute graft-versus-host disease, an immune complication of transplantation, in pediatric patients 2 months of age and older, not for rebuilding tissue. For knee cartilage specifically, the trial evidence is reviewed in whether stem cell therapy can regrow knee cartilage.

How to interpret MSC labels in a study or advertisement

Label you see What it may establish What it does not establish
"Mesenchymal stem cells" That the writer considers the cells stem cells That self-renewal and multilineage potential in the body were shown
"Mesenchymal stromal cells" In culture-expanded MSC preparations, a plastic-adherent mixed population, usually of the same broad type That the cells are stem cells, or that they are not useful
"MSC" alone One of several possible meanings Which claim is being made
A tissue source, such as "adipose-derived" Where the cells came from That cells from different sources are equivalent
A marker panel, such as "CD73, CD90, CD105 positive" That the population matches common identification criteria Stemness, potency or clinical effect
"Culture-expanded" That cells were grown in a laboratory before use Safety, effectiveness or FDA approval

When reading any MSC claim, check four things: the tissue source, how the cells were processed or grown, how they were characterized, and whether controlled human studies of that exact preparation measured the outcome being promised.

Does MSC always mean a stem cell? No. The acronym is used for both stem and stromal cells, and ISCT recommends “stromal” unless rigorous evidence of stemness is shown.

Where can I learn how adult and embryonic stem cells differ? That is a separate distinction about where stem cells come from and how many cell types they can become, covered in adult stem cells vs. embryonic stem cells.

Every stop on the Stem cell basics line

  1. Adult Stem Cells vs. Embryonic Stem Cells: How Are They Different?
  2. Are Mesenchymal Stem Cells and Mesenchymal Stromal Cells the Same Thing?
  3. Autologous vs. Allogeneic Stem Cells: What Does Each Term Mean?
  4. Bone Marrow vs. Fat-Derived Stem Cells: How Do the Sources Compare?
  5. What Is Bone Marrow Aspirate Concentrate (BMAC), and What Does It Contain?
  6. What Are Exosomes, and What Do They Do in the Body?

Reader comments

Leave a note on this stop

Your email address will not be published. Required fields are marked *